Product Details

Product Name : 
Imatinib
Strength : 
100mg
Dosage Form : 
Tablets
Size : 
90
NDC : 
67877063390
UPC : 
367877633909
OTC/RX : 
Rx
Reference Brand : 
Gleevec
Case Qty : 
12
Case Weight (lbs) : 
1.55
Case Dimentions (inches) : 
6.5x4.58x8.58
Product Shelf Life : 
24 months
Shape : 
round, biconvex
Color : 
Dark yellow to Brownish/Orange
Imprint/Markings : 
"S" on one side and "1" on other
Therapeutic Class : 
Anticancer
Indications for Use : 
indicated for the treatment of newly diagnosed adult and pediatric patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase, patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in blast crisis (BC), accelerated phase (AP), or in chronic phase (CP) after failure of interferon-alpha therapy, adult patients with relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), adult patients with myelodysplastic/ myeloproliferative diseases (MDS/MPD) associated with PDGFR (platelet-derived growth factor receptor) gene re-arrangements as determined with an FDA-approved test, adult patients with aggressive systemic mastocytosis (ASM) without the D816V c-Kit mutation as determined with an FDA-approved test or with c-Kit mutational status unknown, adult patients with hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukemia (CEL) who have the FIP1L1-PDGFRa fusion kinase (mutational analysis or FISH demonstration of CHIC2 allele deletion) and for patients with HES and/or CEL who are FIP1L1-PDGFRa fusion kinase negative or unknown, adult patients with unresectable, recurrent and/or metastatic dermatofibrosarcoma protuberans (DFSP)
Inactive Ingrediant : 
Povidone, Madnesium stearate, Hypromelloses, Ferric Oxide Yellow, Polyethylene Glycol, Talc, Titanium Dioxide, Ferric Oxide Red